BTIG, LLC, a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services, has announced that Mark Secrest has joined the firm as a Managing Director within its Healthcare Investment Banking Group.
Mr. Secrest will focus on the medical devices, life sciences tools and diagnostics industries, increasingly active areas of growth for the firm. Over the last year, BTIG has significantly built out its Investment Banking Group with a team of seasoned industry professionals.
KC Stone, Managing Director and Head of Healthcare Investment Banking at BTIG, noted, “Mark’s extensive M&A experience and transactional expertise make him an exceptional addition to our Healthcare Investment Banking Group. His unique perspective and in-depth knowledge will be invaluable to our clients.”
Mr. Secrest has over 25 years of investment banking experience, most recently as a Managing Director and Head of Medical Devices M&A within the Healthcare Investment Banking Group at Stifel. Previously, he was Head of Medical Devices M&A and Chairman of the Fairness Opinion Review Committee at Cowen. Earlier in his career, Mr. Secrest spent time in the M&A Groups at UBS Securities and Kidder, Peabody.
“Mark brings a wealth of experience to the firm,” said Graham Powis, Managing Director and Head of Investment Banking at BTIG. “With a deep understanding of the medical devices, life sciences tools and diagnostics landscape, and as a skilled M&A professional, he will greatly complement our substantial capabilities in the sector.”
